Causes of death
. | CD8+ T-cell dose . | . | . | ||
|---|---|---|---|---|---|
. | No. patients at or above 50th percentile . | No. patients below 50th percentile . | P . | ||
| Relapse | 3 | 14 | .002 | ||
| Chronic GVHD | 6 | 1 | .10 | ||
| Acute GVHD | 1 | 1 | 1.0 | ||
| Infection/multi-organ failure | 5 | 4 | 1.0 | ||
| Hemorrhage | 0 | 1 | .49 | ||
. | CD8+ T-cell dose . | . | . | ||
|---|---|---|---|---|---|
. | No. patients at or above 50th percentile . | No. patients below 50th percentile . | P . | ||
| Relapse | 3 | 14 | .002 | ||
| Chronic GVHD | 6 | 1 | .10 | ||
| Acute GVHD | 1 | 1 | 1.0 | ||
| Infection/multi-organ failure | 5 | 4 | 1.0 | ||
| Hemorrhage | 0 | 1 | .49 | ||
GVHD indicates graft-versus-host disease. For patients at or above the 50th percentile, n = 32; for those below the 50th percentile, n = 31.